ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
NASDAQ:ATAI
Price:
1.91 USD
-1.55%
Market Closed
Updated:
May 15, 2024
ATAI Life Sciences NV
Cash from Investing Activities
|
ATAI Life Sciences NV
Cash from Investing Activities Peer Comparison
Comparables:
BAYN
MRK
93M1
DMP
PSG
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Investing Activities
-$53.3m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Cash from Investing Activities
-€3.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-3%
|
|
|
Merck KGaA
XETRA:MRK
|
Cash from Investing Activities
-€1.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Investing Activities
-€9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Investing Activities
-€415.4m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Investing Activities
-€787k
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ATAI Life Sciences NV's Cash from Investing Activities?
Cash from Investing Activities
-53.3m
USD
-53.3m
USD
Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Cash from Investing Activities amounts to -53.3m USD.
What is ATAI Life Sciences NV's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-24%
-24%
Over the last year, the Cash from Investing Activities growth was 39%. The average annual Cash from Investing Activities growth rates for ATAI Life Sciences NV have been -24% over the past three years .
You don't have any saved screeners yet
